Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01594723
Recruitment Status : Active, not recruiting
First Posted : May 9, 2012
Last Update Posted : August 25, 2020
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 20, 2015
Estimated Study Completion Date : December 31, 2021
Certification/Extension First Submitted : September 3, 2015